Protalix BioTherapeutics Inc (PLX)

1.80 +0.02 (+1.12%) USD  |  NYAM  |  Dec 26, 13:39
More

Protalix BioTherapeutics Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for PLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Quarter Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Accuray Inc Upgrade
AIM ImmunoTech Inc Upgrade
Perspective Therapeutics Inc Upgrade
Electromed Inc Upgrade
Armata Pharmaceuticals Inc Upgrade

Revenue Estimates for Current Quarter Related Metrics

Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade